These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7905546)

  • 1. Adjuvant systemic therapy for breast cancer: a tale of relapse and survival.
    Pritchard K
    Lancet; 1994 Feb; 343(8894):370-1. PubMed ID: 7905546
    [No Abstract]   [Full Text] [Related]  

  • 2. Stopping metastases at their source.
    Hellman S
    N Engl J Med; 1997 Oct; 337(14):996-7. PubMed ID: 9309106
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of systemic adjuvant treatment on first sites of breast cancer relapse.
    Goldhirsch A; Gelber RD; Price KN; Castiglione M; Coates AS; Rudenstam CM; Collins J; Lindtner J; Hacking A; Marini G
    Lancet; 1994 Feb; 343(8894):377-81. PubMed ID: 7905550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer.
    Toi M; Yamashiro H; Tsuji W
    Breast Cancer; 2009; 16(3):207-18. PubMed ID: 19259765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Ragaz J; Olivotto IA; Spinelli JJ; Phillips N; Jackson SM; Wilson KS; Knowling MA; Coppin CM; Weir L; Gelmon K; Le N; Durand R; Coldman AJ; Manji M
    J Natl Cancer Inst; 2005 Jan; 97(2):116-26. PubMed ID: 15657341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local therapy and survival in breast cancer.
    Punglia RS; Morrow M; Winer EP; Harris JR
    N Engl J Med; 2007 Jun; 356(23):2399-405. PubMed ID: 17554121
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy.
    Synnestvedt M; Borgen E; Russnes HG; Kumar NT; Schlichting E; Giercksky KE; Kåresen R; Nesland JM; Naume B
    Acta Oncol; 2013 Jan; 52(1):91-101. PubMed ID: 22934555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemotherapy for breast cancer.
    Dent DM
    S Afr Med J; 1977 Oct; 52(18):714-6. PubMed ID: 601641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adjuvant chemotherapy on the natural history and likelihood of therapeutic efficacy in advanced breast cancer patients: a critical literature review.
    Alexandre J; Faivre S; Sutherland W; Cvitkovic E
    Cancer Treat Rev; 1998 Dec; 24(6):393-406. PubMed ID: 10189406
    [No Abstract]   [Full Text] [Related]  

  • 10. Who should not undergo breast conservation?
    Nijenhuis MV; Rutgers EJ
    Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of delayed radiation therapy on local control in breast conservation therapy.
    Meek AG; Park TL; Weiss TA; Bethune WA
    Radiology; 1996 Sep; 200(3):615-9. PubMed ID: 8756905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multi-modal treatment in breast cancer. The prognostic role and correlation between relapse and metastasis].
    Munteanu A; Munteanu F; Bild E
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):941-6. PubMed ID: 20191859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant therapy for breast cancer patients: treatment decision tree from a French cancer network].
    Bachelot T; Ray-Coquard I; Coeffic D; Barletta H; Gouttebel MC; Mayer B; Muron T; Laroche GD; Vincent M; Farsi F; Philip T
    Bull Cancer; 2002 Oct; 89(10):897-903. PubMed ID: 12441282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More evidence that locoregional radiation therapy improves survival: what should we do?
    Whelan T; Levine M
    J Natl Cancer Inst; 2005 Jan; 97(2):82-4. PubMed ID: 15657332
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening and breast cancer.
    Retsky MW; Demicheli R; Hrushesky WJ
    N Engl J Med; 2006 Feb; 354(7):767-9; author reply 767-9. PubMed ID: 16482676
    [No Abstract]   [Full Text] [Related]  

  • 16. Conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem-cell transplantation in high-risk breast cancer.
    Tallman MS; Gray R; Robert NJ; LeMaistre CF; Osborne CK; Vaughan WP; Gradishar WJ; Pisansky TM; Fetting J; Paietta E; Lazarus HM
    N Engl J Med; 2003 Jul; 349(1):17-26. PubMed ID: 12840088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.
    Wapnir IL; Aebi S; Geyer CE; Zahrieh D; Gelber RD; Anderson SJ; Robidoux A; Bernhard J; Maibach R; Castiglione-Gertsch M; Coates AS; Piccart MJ; Clemons MJ; Costantino JP; Wolmark N; ; ;
    Clin Breast Cancer; 2008 Jun; 8(3):287-92. PubMed ID: 18650162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing relapse beyond 5 years: the MA.17 extended adjuvant trial.
    Goss PE
    Semin Oncol; 2006 Apr; 33(2 Suppl 7):S8-12. PubMed ID: 16730271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The adjuvant chemotherapy of N(-) patients with breast cancer--when is it indicated?].
    Deliĭski T; Baĭchev G; Davidov D; Gorchev G; Velkova A
    Akush Ginekol (Sofiia); 1996; 35(4):20-1. PubMed ID: 9254560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of local control in an era of systemic therapy.
    Hellman S; Weichselbaum RR
    Nat Clin Pract Oncol; 2005 Feb; 2(2):60-1. PubMed ID: 16264859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.